Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to 0.73%.

  • Atara Biotherapeutics' Return on Invested Capital fell 20300.0% to 0.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73%, marking a year-over-year decrease of 20300.0%. This contributed to the annual value of 0.85% for FY2024, which is 209900.0% up from last year.
  • Latest data reveals that Atara Biotherapeutics reported Return on Invested Capital of 0.73% as of Q3 2025, which was down 20300.0% from 0.18% recorded in Q2 2025.
  • Atara Biotherapeutics' 5-year Return on Invested Capital high stood at 13.44% for Q3 2023, and its period low was 8.47% during Q2 2023.
  • In the last 4 years, Atara Biotherapeutics' Return on Invested Capital had a median value of 0.53% in 2025 and averaged 0.8%.
  • Over the last 5 years, Atara Biotherapeutics' Return on Invested Capital had its largest YoY gain of 101800bps in 2024, and its largest YoY loss of -121400bps in 2024.
  • Atara Biotherapeutics' Return on Invested Capital (Quarter) stood at 1.79% in 2022, then skyrocketed by 306bps to 3.68% in 2023, then plummeted by -76bps to 0.89% in 2024, then crashed by -182bps to 0.73% in 2025.
  • Its Return on Invested Capital was 0.73% in Q3 2025, compared to 0.18% in Q2 2025 and 0.18% in Q1 2025.